Sarepta Therapeutics Inc (SRPT)
114.23
+3.73
(+3.38%)
USD |
NASDAQ |
Nov 22, 16:00
114.23
0.00 (0.00%)
After-Hours: 20:00
Sarepta Therapeutics Stock Buybacks (Quarterly)
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 4.285M |
| March 31, 2020 | -316.34M |
| December 31, 2019 | -0.001M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | -0.089M |
| March 31, 2019 | -365.26M |
| December 31, 2018 | -513.41M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | -353.96M |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 0.149M |
| September 30, 2016 | -327.45M |
| June 30, 2016 | -37.50M |
| March 31, 2016 | |
| December 31, 2015 | -119.92M |
| September 30, 2015 | 0.00 |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | 9.698M |
| Date | Value |
|---|---|
| September 30, 2014 | -5.43M |
| June 30, 2014 | -98.77M |
| March 31, 2014 | |
| December 31, 2013 | -2.035M |
| September 30, 2013 | -139.04M |
| June 30, 2013 | -1.922M |
| March 31, 2013 | -2.993M |
| December 31, 2012 | -157.28M |
| September 30, 2012 | -21.40M |
| June 30, 2012 | 0.00 |
| March 31, 2012 | -0.001M |
| December 31, 2011 | 0.00 |
| September 30, 2011 | -0.032M |
| June 30, 2011 | -32.23M |
| March 31, 2011 | -0.116M |
| December 31, 2010 | -0.036M |
| September 30, 2010 | -2.506M |
| June 30, 2010 | -0.019M |
| March 31, 2010 | 0.00 |
| December 31, 2009 | -0.058M |
| September 30, 2009 | -32.27M |
| June 30, 2009 | -0.049M |
| March 31, 2009 | -15.46M |
| December 31, 2008 | -0.0375M |
| September 30, 2008 | 0.0005M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-316.34M
Minimum
Mar 2020
4.285M
Maximum
Jun 2020
-62.41M
Average
--
Median
Sep 2020
Stock Buybacks (Quarterly) Benchmarks
| Eli Lilly and Co | 446.10M |
| Catalyst Pharmaceuticals Inc | 0.00 |
| Regeneron Pharmaceuticals Inc | 600.60M |
| Vertex Pharmaceuticals Inc | 391.40M |
| Viking Therapeutics Inc | -46.66M |